Literature DB >> 24871699

NMDA receptor blockade in the prelimbic cortex activates the mesolimbic system and dopamine-dependent opiate reward signaling.

Huibing Tan1, Laura G Rosen, Garye A Ng, Walter J Rushlow, Steven R Laviolette.   

Abstract

RATIONALE: N-Methyl-D-aspartate (NMDA) receptors in the medial prefrontal cortex (mPFC) are involved in opiate reward processing and modulate sub-cortical dopamine (DA) activity. NMDA receptor blockade in the prelimbic (PLC) division of the mPFC strongly potentiates the rewarding behavioural properties of normally sub-reward threshold doses of opiates. However, the possible functional interactions between cortical NMDA and sub-cortical DAergic motivational neural pathways underlying these effects are not understood.
OBJECTIVE: This study examines how NMDA receptor modulation in the PLC influences opiate reward processing via interactions with sub-cortical DAergic transmission. We further examined whether direct intra-PLC NMDA receptor modulation may activate DA-dependent opiate reward signaling via interactions with the ventral tegmental area (VTA).
METHODS: Using an unbiased place conditioning procedure (CPP) in rats, we performed bilateral intra-PLC microinfusions of the competitive NMDA receptor antagonist, (2R)-amino-5-phosphonovaleric acid (AP-5), prior to behavioural morphine place conditioning and challenged the rewarding effects of morphine with DA receptor blockade. We next examined the effects of intra-PLC NMDA receptor blockade on the spontaneous activity patterns of presumptive VTA DA or GABAergic neurons, using single-unit, extracellular in vivo neuronal recordings.
RESULTS: We show that intra-PLC NMDA receptor blockade strongly activates sub-cortical DA neurons within the VTA while inhibiting presumptive non-DA GABAergic neurons. Behaviourally, NMDA receptor blockade activates a DA-dependent opiate reward system, as pharmacological blockade of DA transmission blocked morphine reward only in the presence of intra-PLC NMDA receptor antagonism.
CONCLUSIONS: These findings demonstrate a cortical NMDA-mediated mechanism controlling mesolimbic DAergic modulation of opiate reward processing.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24871699     DOI: 10.1007/s00213-014-3616-0

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  39 in total

1.  GABA(A) receptors in the ventral tegmental area control bidirectional reward signalling between dopaminergic and non-dopaminergic neural motivational systems.

Authors:  S R Laviolette; D van der Kooy
Journal:  Eur J Neurosci       Date:  2001-03       Impact factor: 3.386

2.  Inactivation of the basolateral amygdala during opiate reward learning disinhibits prelimbic cortical neurons and modulates associative memory extinction.

Authors:  Ninglei Sun; Steven R Laviolette
Journal:  Psychopharmacology (Berl)       Date:  2012-03-21       Impact factor: 4.530

3.  NMDA receptor hypofunction in the prelimbic cortex increases sensitivity to the rewarding properties of opiates via dopaminergic and amygdalar substrates.

Authors:  Stephanie F Bishop; Nicole M Lauzon; Melanie Bechard; Shervin Gholizadeh; Steven R Laviolette
Journal:  Cereb Cortex       Date:  2010-04-14       Impact factor: 5.357

4.  NMDA receptor hypofunction produces opposite effects on prefrontal cortex interneurons and pyramidal neurons.

Authors:  Houman Homayoun; Bita Moghaddam
Journal:  J Neurosci       Date:  2007-10-24       Impact factor: 6.167

5.  Repeated cocaine self-administration alters processing of cocaine-related information in rat prefrontal cortex.

Authors:  WenLin Sun; George V Rebec
Journal:  J Neurosci       Date:  2006-07-26       Impact factor: 6.167

6.  Neurons in medial prefrontal cortex signal memory for fear extinction.

Authors:  Mohammed R Milad; Gregory J Quirk
Journal:  Nature       Date:  2002-11-07       Impact factor: 49.962

7.  Deprivation state switches the neurobiological substrates mediating opiate reward in the ventral tegmental area.

Authors:  K Nader; D van der Kooy
Journal:  J Neurosci       Date:  1997-01-01       Impact factor: 6.167

8.  Activation of glutamatergic neurotransmission by ketamine: a novel step in the pathway from NMDA receptor blockade to dopaminergic and cognitive disruptions associated with the prefrontal cortex.

Authors:  B Moghaddam; B Adams; A Verma; D Daly
Journal:  J Neurosci       Date:  1997-04-15       Impact factor: 6.167

9.  Attenuation of brain response to heroin correlates with the reinstatement of heroin-seeking in rats by fMRI.

Authors:  Feng Luo; Zheng-Xiong Xi; Gaohong Wu; Chuang Liu; Eliot L Gardner; Shi-Jiang Li
Journal:  Neuroimage       Date:  2004-07       Impact factor: 6.556

10.  Acute effect of methadone maintenance dose on brain FMRI response to heroin-related cues.

Authors:  Daniel D Langleben; Kosha Ruparel; Igor Elman; Samantha Busch-Winokur; Ramapriyan Pratiwadi; James Loughead; Charles P O'Brien; Anna R Childress
Journal:  Am J Psychiatry       Date:  2007-12-03       Impact factor: 18.112

View more
  8 in total

1.  Conduct Disorder Symptoms and Illicit Drug Use in Juvenile Justice Involved Youth: The Reciprocal Relationship Between Positive Illicit Drug-Use Attitudes and Illicit Drug Use.

Authors:  Haley M Kolp; Alexandra R Hershberger; Jasmyn Sanders; Miji Um; Matthew Aalsma; Melissa A Cyders
Journal:  Subst Use Misuse       Date:  2017-11-29       Impact factor: 2.164

Review 2.  Unravelling the Link Between Prenatal Stress, Dopamine and Substance Use Disorder.

Authors:  Verónica Pastor; Marta Cristina Antonelli; María Eugenia Pallarés
Journal:  Neurotox Res       Date:  2016-10-24       Impact factor: 3.911

Review 3.  Do specific NMDA receptor subunits act as gateways for addictive behaviors?

Authors:  F W Hopf
Journal:  Genes Brain Behav       Date:  2016-11-18       Impact factor: 3.449

4.  GABA-Mediated Inactivation of Medial Prefrontal and Agranular Insular Cortex in the Rat: Contrasting Effects on Hunger- and Palatability-Driven Feeding.

Authors:  Brian A Baldo; Robert C Spencer; Ken Sadeghian; Jesus D Mena
Journal:  Neuropsychopharmacology       Date:  2015-07-23       Impact factor: 7.853

Review 5.  Glutamatergic Systems and Memory Mechanisms Underlying Opioid Addiction.

Authors:  Jasper A Heinsbroek; Taco J De Vries; Jamie Peters
Journal:  Cold Spring Harb Perspect Med       Date:  2021-03-01       Impact factor: 6.915

6.  The Role of Dopamine D1 and D3 Receptors in N-Methyl-D-Aspartate (NMDA)/GlycineB Site-Regulated Complex Cognitive Behaviors following Repeated Morphine Administration.

Authors:  Yunpeng Wang; Fangyuan Yin; Hao Guo; Jing Zhang; Peng Yan; Jianghua Lai
Journal:  Int J Neuropsychopharmacol       Date:  2017-07-01       Impact factor: 5.176

7.  A Conantokin Peptide Con-T[M8Q] Inhibits Morphine Dependence with High Potency and Low Side Effects.

Authors:  Zhuguo Liu; Zheng Yu; Shuo Yu; Cui Zhu; Mingxin Dong; Wenxiang Mao; Jie Hu; Mary Prorok; Ruibin Su; Qiuyun Dai
Journal:  Mar Drugs       Date:  2021-01-19       Impact factor: 5.118

Review 8.  Brain Reward Circuits in Morphine Addiction.

Authors:  Juhwan Kim; Suji Ham; Heeok Hong; Changjong Moon; Heh-In Im
Journal:  Mol Cells       Date:  2016-08-09       Impact factor: 5.034

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.